These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 36751831)
1. Effect of omega-3 fatty acid use on sepsis and mortality in patients with Covıd-19. Erdem D; Segmen F; Uysal E; Kilicarslan G Niger J Clin Pract; 2023 Jan; 26(1):102-108. PubMed ID: 36751831 [TBL] [Abstract][Full Text] [Related]
2. Omega-3 fatty acid supplementation is associated with favorable outcomes in patients with sepsis: an updated meta-analysis. Wang C; Han D; Feng X; Wu J J Int Med Res; 2020 Dec; 48(12):300060520953684. PubMed ID: 33373266 [TBL] [Abstract][Full Text] [Related]
3. Cost analysis of Omega-3 supplementation in critically ill patients with sepsis. Kyeremanteng K; Shen J; Thavorn K; Fernando SM; Herritt B; Chaudhuri D; Tanuseputro P Clin Nutr ESPEN; 2018 Jun; 25():63-67. PubMed ID: 29779820 [TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of omega-3 fatty acid supplements in parenteral nutrition therapy in hospitals: a discrete event simulation model. Pradelli L; Eandi M; Povero M; Mayer K; Muscaritoli M; Heller AR; Fries-Schaffner E Clin Nutr; 2014 Oct; 33(5):785-92. PubMed ID: 24345520 [TBL] [Abstract][Full Text] [Related]
5. [The effect of ω-3 fatty acid supplementation in parenteral nutrition on the outcome of patients with sepsis: a systematic review and meta-analysis]. Mo Y; Hu X; Chang L; Ma P Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):142-7. PubMed ID: 24598286 [TBL] [Abstract][Full Text] [Related]
6. Correlation analysis of omega-3 fatty acids and mortality of sepsis and sepsis-induced ARDS in adults: data from previous randomized controlled trials. Chen H; Wang S; Zhao Y; Luo Y; Tong H; Su L Nutr J; 2018 May; 17(1):57. PubMed ID: 29859104 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of omega-3 fatty acids for hospitalized COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials. Yue HY; Zeng J; Wang Y; Deng MJ; Peng W; Tan X; Jiang H Asia Pac J Clin Nutr; 2023 Sep; 32(3):308-320. PubMed ID: 37789651 [TBL] [Abstract][Full Text] [Related]
9. ω-3 Fatty-Acid Enriched Parenteral Nutrition in Hospitalized Patients: Systematic Review With Meta-Analysis and Trial Sequential Analysis. Pradelli L; Mayer K; Klek S; Omar Alsaleh AJ; Clark RAC; Rosenthal MD; Heller AR; Muscaritoli M JPEN J Parenter Enteral Nutr; 2020 Jan; 44(1):44-57. PubMed ID: 31250474 [TBL] [Abstract][Full Text] [Related]
10. The effect of polyunsaturated fatty acids on the severity and mortality of COVID patients: A systematic review. Mazidimoradi A; Alemzadeh E; Alemzadeh E; Salehiniya H Life Sci; 2022 Jun; 299():120489. PubMed ID: 35358595 [TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
12. Letter to the editor: Study Summary - Randomized Control Trial of Omega-3 Fatty Acid Supplementation for the Treatment of COVID-19 Related Olfactory Dysfunction. Lerner D; Garvey K; Arrighi-Allisan A; Filimonov A; Filip P; Liu K; Ninan S; Schaberg M; Colley P; Del Signore A; Govindaraj S; Iloreta AM Trials; 2020 Nov; 21(1):942. PubMed ID: 33225989 [TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial investigating the effects of parenteral fish oil on survival outcomes in critically ill patients with sepsis: a pilot study. Hall TC; Bilku DK; Al-Leswas D; Neal CP; Horst C; Cooke J; Metcalfe MS; Dennison AR JPEN J Parenter Enteral Nutr; 2015 Mar; 39(3):301-12. PubMed ID: 24408035 [TBL] [Abstract][Full Text] [Related]
15. Beneficial Effects of Omega-3 Supplement to the Enteral Feeding in Children With Mild to Moderate Sepsis. Al-Biltagi MA; Abo-Elezz AA; Abd-Elhafez MA; Mabrouk MM; Suliman GA J Intensive Care Med; 2017 Mar; 32(3):212-217. PubMed ID: 26704762 [TBL] [Abstract][Full Text] [Related]
16. The role of ω-3 fatty acid supplemented parenteral nutrition in critical illness in adults: a systematic review and meta-analysis. Palmer AJ; Ho CK; Ajibola O; Avenell A Crit Care Med; 2013 Jan; 41(1):307-16. PubMed ID: 23128380 [TBL] [Abstract][Full Text] [Related]
18. Omega-3 polyunsaturated fatty acids supplementation improve clinical symptoms in patients with Covid-19: A randomised clinical trial. Sedighiyan M; Abdollahi H; Karimi E; Badeli M; Erfanian R; Raeesi S; Hashemi R; Vahabi Z; Asanjarani B; Mansouri F; Abdolahi M Int J Clin Pract; 2021 Dec; 75(12):e14854. PubMed ID: 34516692 [TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
20. Effect of curcumin-pipeine supplementation on clinical status, mortality rate, oxidative stress, and inflammatory markers in critically ill ICU patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial. Askari G; Alikiaii B; Soleimani D; Sahebkar A; Mirjalili M; Feizi A; Iraj B; Bagherniya M Trials; 2021 Jul; 22(1):434. PubMed ID: 34229742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]